Form 4: Klobuchar Acquires Revvity Stock Units

Michael A. Klobuchar, a Director at Revvity, Inc., acquired restricted stock units representing 1,015 shares of common stock on May 7, 2026.

Summary

• Michael A. Klobuchar, a Director at Revvity, Inc. (RVTY), acquired 1,015 restricted stock units (RSUs) on May 7, 2026. These RSUs represent a contingent right to receive one share of common stock per unit.
• The RSUs are scheduled to fully vest on April 27, 2027, contingent upon Klobuchar's continued service through that date.
• Vesting can also occur earlier upon Klobuchar's death, disability, or qualifying retirement, or upon termination of service within 12 months following a change in control.
• Following this transaction, Klobuchar beneficially owns 6,103 shares of common stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a standard equity compensation grant to a director rather than an open-market purchase or sale that might indicate a stronger market sentiment.

Positives

• Director acquisition of stock units can signal confidence in the company's future prospects.
• The acquisition of RSUs is a form of equity compensation, aligning management's interests with shareholders.

Negatives

• The acquisition is a grant of restricted stock units, not an open market purchase, indicating it's part of compensation rather than an investment decision based on current market valuation.

Risks

• Vesting is contingent on continued service, meaning the shares may not be fully realized if service is terminated.
• The RSUs are subject to vesting conditions related to death, disability, retirement, or change in control, introducing potential uncertainties.
• A change in control event could accelerate vesting, but termination within 12 months following such an event is also a condition.

Future Outlook

The restricted stock units are set to vest on April 27, 2027, contingent upon the reporting person's continued service, or earlier upon specific events like death, disability, qualifying retirement, or termination following a change in control.

Industry Context

StockSavvy.ai notes that insider transactions, particularly grants of equity compensation like restricted stock units, are common within the life sciences and diagnostics industry as a tool for executive retention and aligning long-term incentives.

Stakeholder Impact

• Shareholders: The grant of RSUs aligns director incentives with long-term shareholder value, but the immediate impact on share price is minimal as it's a compensation event.
• Employees: This transaction is specific to a director and does not directly impact general employee compensation structures.
• Management: The RSUs serve as a retention and incentive tool for the director.

Next Steps

• Vesting of restricted stock units on April 27, 2027, or earlier under specified conditions.
• Continued service by Michael A. Klobuchar through the vesting date.

Key Dates

Keywords

Revvity, RVTY, Form 4, SEC Filing, Insider Transaction, Stock Options, Restricted Stock Units, Director, Equity Compensation, Beneficial Ownership